Home > Analytics > HEALTHCARE GLOBAL ENTERPRISES

HEALTHCARE GLOBAL ENTERPRISES
Intrinsic Value | Fundamental Analysis

BOM : 539787     NSE : HCG    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Mar 18,2024
Price(EOD): ₹ 342.95
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Miscellaneous
MCap: ₹ 4,777.29 Cr
Value of ₹ 1 Lac invested in HEALTHCARE GLOBAL ENTERPRISES
on Mar 18,2019 (price: ₹ 194.00)

₹ 1 L

₹ 1.77 L

1W : 5.6% 1M : -10.8% 1Y : 28%
COMMUNITY POLL
for HEALTHCARE GLOBAL ENTERPRISES
Please provide your vote to see the results
HEALTHCARE GLOBAL ENTERPRISES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Industry Peers & Returns1W1M1Y
HEALTHCARE GLOBAL ENTERPRISES 5.6% -10.8% 28%
SYNGENE INTERNATIONAL -1.6% -10.8% 16.2%
BLS INTERNATIONAL SERVICES 2.7% -7% 126.5%
LATENT VIEW ANALYTICS -7.4% -14.2% 35.7%
QUESS CORP 0.8% -0.4% 39.6%
DELTA CORP -4.2% -11.9% -34.5%
SUN PHARMA ADVANCED RESEARCH COMPANY -3.6% 0.7% 92.3%
SECURITY AND INTELLIGENCE SERVICES INDIA -1.4% 1% 27.6%
JUST DIAL -6.6% -8.5% 33.5%

FUNDAMENTAL ANALYSIS OF HEALTHCARE GLOBAL ENTERPRISES

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF HEALTHCARE GLOBAL ENTERPRISES

 
Valuation Score
[As on : Mar 18,2024 ]

Ratio Consolidated
P/E
P/B
P/S
205.98
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 23.19 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

5.63
P/B Calculated based on Book Value of Rs 848.49 Cr
[Latest Year - Mar2023 - Consolidated Results ]

2.57
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,859.20 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

Financial Ratios →

Insights 💡 HCG is one of the potential top 16% undervalued companies ! Discover More →

FAIR VALUE OF HEALTHCARE GLOBAL ENTERPRISES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-26%
-22%
-20%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF HEALTHCARE GLOBAL ENTERPRISES



HEALTHCARE GLOBAL ENTERPRISES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF HEALTHCARE GLOBAL ENTERPRISES

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0.11
0.1
0.27
0.16
0.47
0.47
0.73
0.56
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF HEALTHCARE GLOBAL ENTERPRISES

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF HEALTHCARE GLOBAL ENTERPRISES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-3.51%
-7.1%
-38.26%
-68.12%
10.64%
4.12%
-2.12%
-18.29%
QtrlyTrend
-4
Latest Qtr: Dec2023
Quarterly Result Analysis →


HEALTHCARE GLOBAL ENTERPRISES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE -2.1% -2.4% 59.2%
S&P BSE ALLCAP -2.3% -1.4% 38%
S&P BSE MIDSMALLCAP -3.9% -5.5% 55.7%
S&P BSE SMALL CAP -4.1% -7.4% 53.4%
No NSE index found

You may also like the below Video Courses


FAQ about HEALTHCARE GLOBAL ENTERPRISES


Is HEALTHCARE GLOBAL ENTERPRISES good for long term investment?

As on Mar 18,2024, the Fundamentals of HEALTHCARE GLOBAL ENTERPRISES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of HEALTHCARE GLOBAL ENTERPRISES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is HEALTHCARE GLOBAL ENTERPRISES UnderValued or OverValued?

As on Mar 18,2024, HEALTHCARE GLOBAL ENTERPRISES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of HEALTHCARE GLOBAL ENTERPRISES ?

As on Mar 18,2024, the Intrinsic Value of HEALTHCARE GLOBAL ENTERPRISES is Rs. 442.46 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 466.03
Fair Value [Median EV / Sales Model] : Rs. 442.46
Fair Value [Median Price / Sales Model] : Rs. 427.00
Estimated Median Fair Value of HEALTHCARE GLOBAL ENTERPRISES : Rs. 442.46

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is HEALTHCARE GLOBAL ENTERPRISES trading at a Premium or Discount?

As on Mar 18,2024, HEALTHCARE GLOBAL ENTERPRISES is trading at a Discount of -22% based on the estimates of Median Intrinsic Value!